Philip Morris opens the week with analyst support, shares in focus on the NYSE
29.06.2026 - 09:04:54 | ad-hoc-news.de
By Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-29, 09:04.
Philip Morris International (US7181721090) enters the new trading week on the NYSE with recent analyst commentary still fresh. Morgan Stanley and Stifel have reiterated a constructive view on the shares in the context of upcoming product launches and the wider tobacco sector backdrop, according to recent notes.
What recent analysts highlight
On June 26, 2026, finance-focused outlets reported that Morgan Stanley raised its price target for Philip Morris from 190 to 200 dollars and maintained an Overweight rating on the shares, citing confidence ahead of the company's planned ZYN Ultra nicotine pouch launch and further IQOS expansion in key markets. MarketBeat data on Philip Morris notes the stock trades in the consumer staples tobacco segment and carries substantial institutional coverage.
Additional analyst commentary from Stifel also emphasizes Philip Morris's transition toward reduced-risk products, with a focus on growth from smoke-free categories while preserving its dividend track record. As summarized by recent analyst aggregation on June 26, the firm expresses increased confidence in the company's strategy and earnings visibility, particularly tied to IQOS penetration and nicotine pouch market share. MarketBeat news on Philip Morris lists these updates among the latest drivers for investor attention.
Consensus picture and sector context
Philip Morris shares are part of the S&P 500 and the consumer staples tobacco industry, a sector that often attracts income-focused investors thanks to comparatively high dividend yields and stable cash flows. Recent consensus data compiled by MarketBeat shows the stock trading around 180.92 dollars at the June 26, 2026 close, with a range between roughly 153 and 192 dollars over the preceding 50 days, underlining a mixed but constructive sentiment in the analyst community. MarketBeat Philip Morris price and range provides the latest trading metrics.
Sector peers such as Altria and British American Tobacco also feature prominently in analyst coverage, with regulatory developments in nicotine products and flavored tobacco shaping the backdrop for all listed players. A June 26 report cited by MarketBeat mentions that tobacco stocks moved after the U.S. Food and Drug Administration proposed regulations on foreign tobacco, a reminder that rule changes can affect volume growth and product mix across the industry. Latest tobacco sector news around Philip Morris traces these headlines.
All news and data on the Philip Morris shares
For more detailed price data, historical performance, and further news on Philip Morris, the topic page and the company's Investor Relations site offer additional context.
The products behind the stock
Philip Morris International generates most of its revenue from combustible cigarette brands such as Marlboro, Parliament and L&M in regions outside the United States, complemented by its smoke-free IQOS heated tobacco systems and related consumables. The group has increasingly positioned IQOS as a core driver of long term growth, with commercial deployment across Europe, Asia and other markets supported by dedicated manufacturing and distribution infrastructure referenced on the company's corporate site.
Where the shares trade today
Philip Morris shares (US7181721090) last traded on the NYSE at 180.92 dollars as of 2026-06-26, 15:59 Eastern Time, based on recent trading data compiled by MarketBeat.
Key data on the Philip Morris shares
- Company: Philip Morris International Inc.
- ISIN: US7181721090
- WKN: A0NDBJ
- Ticker: PM
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 180.92 USD
- Market cap: around 281 billion USD (as of late June 2026, based on recent NYSE data)
- Sector / industry: Consumer Staples / Tobacco
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any kind. All data are based on sources believed to be reliable at the time of publication but may change without notice. Investors should conduct their own research or consult a qualified advisor before making investment decisions.
